Philips Unveils AI-Powered DeviceGuide to Assist in Minimally Invasive Heart Valve Repair

Philips has announced the introduction of DeviceGuide, a new AI-powered solution designed to support physicians during complex, minimally invasive heart valve repair procedures. Developed to work in tandem with the company’s EchoNavigator platform, DeviceGuide enhances real-time visualization of structural heart interventions by tracking repair devices as they move through the beating heart.

The technology, which will debut at London Valves 2025, is tailored for mitral transcatheter edge-to-edge repair (M-TEER)—a delicate procedure used to treat mitral valve regurgitation, a condition that affects more than 35 million people worldwide. For patients who are too high-risk for open-heart surgery, M-TEER offers a life-changing alternative. However, the precision required during this intervention can be challenging, especially when it involves interpreting multiple imaging modalities on separate screens while navigating intricate cardiac anatomy.

DeviceGuide tackles this challenge by using AI to automatically track the tiny mitral valve repair device in real time. It fuses live X-ray and ultrasound images into a single, intuitive 3D visualization of the device within the heart. This enhanced view helps clinicians understand not only the position but also the orientation of the device as they guide it through the bloodstream to the valve site, supporting more confident and precise decision-making during each critical step of the procedure.

“This is Philips’ first AI assisting physicians in real time to visualize and guide heart valve treatment devices as they navigate the beating heart,” said Dr. Atul Gupta, Chief Medical Officer, Diagnosis & Treatment at Philips. “It’s helping doctors in the moment as they are helping their patients with structural heart disease.”

Rather than replacing physician expertise, DeviceGuide is designed to augment it. “By embedding AI into the procedure, DeviceGuide gives physicians an extra pair of eyes—effectively bionic vision—helping them treat more patients safely and confidently,” Dr. Gupta added.

DeviceGuide was created in partnership with Edwards Lifesciences, a global leader in structural heart therapies and the manufacturer of the mitral repair devices used in M-TEER. The collaboration brings together Philips’ strengths in real-time imaging and artificial intelligence with Edwards’ deep procedural knowledge to streamline workflow and enhance procedural success.

“DeviceGuide demonstrates the impact of combining leading imaging and therapy expertise to develop solutions designed around the procedural workflow,” said Mark Stoffels, Business Leader, Image Guided Therapy Systems at Philips. “It’s a model that will shape the future of AI-enabled image-guided structural interventions.”

With DeviceGuide, Philips continues its commitment to integrating advanced imaging and AI technologies to improve patient outcomes and empower clinicians at the point of care.